Banner AI technology

Prometheus MedTech AI is the only startup from Poland to meet with an Intel representative

The Institute of Mother and Child hosted an extraordinary meeting on the future of technology in healthcare, attended by distinguished guests!

Prometheus MedTech AI was the only startup from Poland to participate in discussions about supporting new technologies with Intel, one of the most powerful new-tech companies in the world. Last week, its Chief Information Officer (CIO), Motti Finkelstein, visited Poland.

At the meeting at the Mother and Child Institute, Prometheus Med Tech.AI MedTech AI was represented by its founders: Witor Strzelczyk, Tomasz Bartosiak, and Paweł Kuśmierowski.

The discussions on the future of healthcare technology in the Polish market also included representatives from Intel’s Polish management team, Ricoh USA, Inc., Simplicity Consulting Sp. z o.o., Prometheus MedTech.AI, as well as the directors and representatives of the Department of Artificial Intelligence and Medical Technology Innovation at the Mother and Child Institute.

Since 2024, our startup has been collaborating with IMiD, which has long been committed to innovation and modern technologies to provide patients with access to the best medical care. The Institute is also the initiator and coordinator of the annual MCSC Hospital Leadership Innovation competition for medical startups.

Motti Finkelstein, Chief Information Officer (CIO) at Intel Corporation, is responsible for digital strategies, AI transformation, and collaboration with the startup sector. Intel has been investing in groundbreaking medical technologies for years. The company recognizes AI’s potential in diagnostics, and its capabilities in data analysis, machine learning, and hospital system integration can be key to many innovative projects.

This was the first meeting with enormous potential for collaboration between medicine and technology.

Get to know us

Photo - Prometheus MedTech.AI selected to Top 40 out of 2,626 startups worldwide in Korea’s K-Startup Grand Challenge 2025!

Prometheus MedTech.AI selected to Top 40 out of 2,626 startups worldwide in Korea’s K-Startup Grand Challenge 2025!

Prometheus MedTech.AI has been named one of the Top 40 most promising startups in the prestigious K-Startup Grand Challenge 2025 (KSGC) —…

more +
Photo - Prometheus MedTech.AI at NeoHeart 2025: A Milestone Toward U.S. Market Entry

Prometheus MedTech.AI at NeoHeart 2025: A Milestone Toward U.S. Market Entry

Prometheus MedTech.AI has taken a major step toward its U.S. market entry and future FDA certification by participating in NeoHeart 2025…

more +
Photo - Ultra Echo Scan Among Top 3% of Global Startups – Prometheus MedTech.AI Joins K-Startup Grand Challenge 2025!

Ultra Echo Scan Among Top 3% of Global Startups – Prometheus MedTech.AI Joins K-Startup Grand Challenge 2025!

We’re proud to announce that our innovative solution, Ultra Echo Scan (UES), has been selected among the Top 80 startups worldwide for the…

more +
Photo - Prometheus MedTech.AI Expands U.S. Presence with Clinical Collaborations in New York

Prometheus MedTech.AI Expands U.S. Presence with Clinical Collaborations in New York

We are pleased to announce that the Prometheus MedTech.AI team has recently completed a productive visit to New York City, marking…

more +
Photo - Prometheus MedTech.AI at South Summit 2025: A Milestone in Our Global Journey

Prometheus MedTech.AI at South Summit 2025: A Milestone in Our Global Journey

From the Top 10 Health Startups in Europe to the stage in Madrid — our team joined one of the world’s most prestigious innovation summits to connect, pitch, and share our mission.

more +
Photo - International Expansion of Ultra Echo Scan Supported by EU Funding

International Expansion of Ultra Echo Scan Supported by EU Funding

We are proud to announce that UES Sp. z o.o. has received European Union funding to support the international expansion of our…

more +
Photo - Prometheus MedTech.AI Recognized Among Top 10 Health Startups at South Summit Madrid 2025

Prometheus MedTech.AI Recognized Among Top 10 Health Startups at South Summit Madrid 2025

We are thrilled to announce that Prometheus MedTech.AI has been selected as one of the Top 10 startups in the Health category at South Summit…

more +
Photo - Prometheus MedTech.AI at Wolves Summit 2025: Driving MedTech Innovation from Hospital Partnerships

Prometheus MedTech.AI at Wolves Summit 2025: Driving MedTech Innovation from Hospital Partnerships

Prometheus MedTech.AI was proud to participate in Wolves Summit 2025, one of Central and Eastern Europe’s leading events focused on…

more +
Photo - Prometheus MedTech.AI Secures Deeptech Funding for AI-Based Cardiology Project

Prometheus MedTech.AI Secures Deeptech Funding for AI-Based Cardiology Project

We’re pleased to announce that Prometheus MedTech.AI (LPTW Sp. z o.o.) has been awarded a grant of 400,000 PLN as part…

more +
Photo - Today, Prometheus Med Tech.AI is live from Palo Alto

Today, Prometheus Med Tech.AI is live from Palo Alto

We’re presenting at the “Revolutionizing Healthcare: AI, Technology and Impact” conference, showcasing Prometheus Med Tech.AI – our advanced platform designed…

more +
Photo - Prometheus Med Tech.AI at MCSC Hospital Leadership Innovation Impact Day 2025!

Prometheus Med Tech.AI at MCSC Hospital Leadership Innovation Impact Day 2025!

We had the pleasure of participating in an event that attracted tremendous interest from the medical community and health tech…

more +
Photo - Our technology Ultra Echo Scan awarded at Masters&Robots 2025! Innovation recognized by TVN

Our technology Ultra Echo Scan awarded at Masters&Robots 2025! Innovation recognized by TVN

We’re excited to share that our groundbreaking technology, Ultra Echo Scan, developed as part of the Prometheus Med Tech.AI project,…

more +
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.